Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
NRG-CC009
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Adult (18-64)
Older adult (65+)
EAA173
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Adult (18-64)
Older adult (65+)
EA2197
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
Adult (18-64)
Older adult (65+)
S2209
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Adult (18-64)
Older adult (65+)
Child (birth - 17)
OCU410-101
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Adult (18-64)
Older adult (65+)
A031701
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
Adult (18-64)
Older adult (65+)
NCI-2019-07941
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Adult (18-64)
Older adult (65+)
A021806
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Adult (18-64)
Older adult (65+)
A011801
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Adult (18-64)
Older adult (65+)
S1905
Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Adult (18-64)
Older adult (65+)